---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-085514"
form_type: "8-K"
ticker: "AIDX"
cik: "0001139685"
company_name: "20/20 Biolabs, Inc."
filed_at: "2026-08-05T16:00:42+00:00"
generated_at: "2026-08-05T16:02:10.079914+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# 20/20 Biolabs holds investor webinar on August 5, 2026; no specific financial or operational details released

## Summary
- Company furnished investor presentation for August 5, 2026 webinar under Regulation FD.
- Presentation materials are not incorporated by reference and are not deemed filed with the SEC.
- No financial results, guidance, or material events were disclosed in the filing text or exhibit.

## SEC filing metadata
- accession: 0001213900-26-085514
- form_type: 8-K
- ticker: AIDX
- cik: 0001139685
- company_name: 20/20 Biolabs, Inc.
- filed_at: 2026-08-05T16:00:42+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1139685/000121390026085514/0001213900-26-085514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1139685/000121390026085514/ea0300726-8k_2020bio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-085514
- JSON: https://secwatch.observer/filing/0001213900-26-085514.json
- Plain text: https://secwatch.observer/filing/0001213900-26-085514.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.